{"nodes":[{"id":"HSPB1","type":"gene","has_wiki":true,"wiki_url":"/wiki/genes-hsp27","wiki_entity":"HSPB1"},{"id":"HSP90","type":"gene","has_wiki":true,"wiki_url":"/wiki/proteins-hsp90","wiki_entity":"HSP90"},{"id":"HSP27","type":"gene","has_wiki":true,"wiki_url":"/wiki/proteins-hsp27-protein","wiki_entity":"HSP27"},{"id":"MAPK14/PRMT1","type":"gene"},{"id":"neurodegeneration","type":"disease","has_wiki":true,"wiki_url":"/entity/Neurodegeneration","wiki_entity":"Neurodegeneration"}],"edges":[{"source_id":"MAPK14/PRMT1","source_type":"gene","target_id":"neurodegeneration","target_type":"disease","relation":"promoted: p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43 Phosphorylation-Methy","evidence_strength":0.615,"evidence_sources":"[\"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651\", \"{'claim': 'P38\\u03b1 phosphorylation and PRMT1 methylation have opposing roles in TDP-43 proteinopathy - PRMT1-mediated methylation opposes p38\\u03b1 phosphorylation in driving TDP-43 pathology', 'pmid': '39817908'}\", \"{'claim': \\\"P38\\u03b1 inhibitors (neflamapimod) are in Phase 2 trials for Alzheimer's and DLB with demonstrated CNS penetration and favorable safety profile\\\", 'pmid': 'NCT05869669'}\", \"{'claim': \\\"mRNA 3'-UTR binding pathway enrichment with TARDBP (GO:0003730, p=2.73e-08) supports the methylation-phosphorylation axis in RNA metabolism\\\", 'pmid': '39817908'}\", \"{'claim': 'Neflamapimod showed reversal of synaptic dysfunction in mild AD at 40mg BID oral dosing with good tolerability', 'pmid': 'NCT05869669'}\", \"{'claim': 'Methylosome co-localization of PRMT1/PRMT5 with TARDBP confirmed by STRING analysis (GO:0034709, p=9.82e-06)', 'pmid': '39817908'}\"]","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-13T05:27:54-07:00","edge_type":"promoted_hypothesis","source_canonical_id":"mapk14_prmt1","target_canonical_id":"ent-rese-6f3dc74d","epistemic_status":"speculative","trust_score":null,"confidence_interval":null,"trust_computed_at":null,"id":"promoted-h-ccc05373","trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}"},{"source_id":"HSP27","source_type":"gene","target_id":"HSPB1","target_type":"gene","relation":"co_discussed","evidence_strength":0.4,"evidence_sources":"hypothesis:h-ff0d545d","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-16T18:27:54.037460-07:00","edge_type":"hypothesis_cooccurrence","source_canonical_id":"ent-gene-bb7f16c8","target_canonical_id":"ent-gene-8a39255c","epistemic_status":"speculative","trust_score":null,"confidence_interval":null,"trust_computed_at":null,"id":null,"trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}"},{"source_id":"HSP90","source_type":"gene","target_id":"HSPB1","target_type":"gene","relation":"co_discussed","evidence_strength":0.4,"evidence_sources":"hypothesis:h-ff0d545d","analysis_id":"SDA-2026-04-12-gap-debate-20260410-113051-5dce7651","created_at":"2026-04-16T18:27:54.037460-07:00","edge_type":"hypothesis_cooccurrence","source_canonical_id":"Hsp90","target_canonical_id":"ent-gene-8a39255c","epistemic_status":"speculative","trust_score":null,"confidence_interval":null,"trust_computed_at":null,"id":null,"trust_confidence_low":0.3,"trust_confidence_high":0.7,"trust_computation_factors":"{}"}],"pagination":{"limit":5000,"offset":0,"total_edges":3,"total_nodes":5,"has_more":false}}